The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determination of clinical benefit among patients with radiological stable disease to immune checkpoint inhibitors.
 
Jia Luo
No Relationships to Disclose
 
Song Wu
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Hira Rizvi
No Relationships to Disclose
 
Qu Zhang
Employment - AstraZeneca/MedImmune; Bristol-Myers Squibb
Stock and Other Ownership Interests - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Jacklynn V. Egger
No Relationships to Disclose
 
Juan C. Osorio
No Relationships to Disclose
 
Adam Jacob Schoenfeld
(OPTIONAL) Uncompensated Relationships - Iovance Biotherapeutics
 
Andrew J. Plodkowski
No Relationships to Disclose
 
Michelle S. Ginsberg
No Relationships to Disclose
 
Ashok Kumar Gupta
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca; MacroGenics
Patents, Royalties, Other Intellectual Property - AstraZeneca; Bristol-Myers Squibb
 
Rajiv Raja
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patent pending on Tumor Mutational Burden (TMB) as a biomarker
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Genentech/Roche; Novartis; Pfizer; Sanofi/Aventis
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Genentech; Pfizer
Other Relationship - Genentech/Roche; Memorial Sloan-Kettering Cancer Center
 
Matthew D. Hellmann
Stock and Other Ownership Interests - Arcus Biosciences; Immunai; Shattuck Labs; Shattuck Labs
Consulting or Advisory Role - Achilles Therapeutics; Arcus Biosciences; AstraZeneca/MedImmune; Blueprint Medicines; Bristol-Myers Squibb; Genentech; Immunai; Merck; Mirati Therapeutics; Natera; Nektar; Shattuck Labs; Syndax
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - A patent has been filed by Memorial Sloan Kettering (PCT/US2015/062208) for the use of tumor mutation burden for prediction of immunotherapy efficacy, and which is licensed to Personal Genome Diagnostics. (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Lilly